Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer-MedSci.cn

Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer

Yan, MN; Han, MT; Yang, XX; Shen, R; Wang, H; Zhang, LB; Xia, S; Yang, PF; Zhai, GH; Shao, QX

Zhai, GH (corresponding author), Nanjing Med Univ, Affiliated Suzhou Hosp Nanjing Med Univ, Suzhou Municipal Hosp, Gusu Sch,Dept Lab Med, 242 Guangji Rd, Suzhou 215008, Jiangsu, Peoples R China.; Shao, QX (corresponding author), Jiangsu Univ, Sch Med, Reprod Sci Inst, Dept Immunol,Key Lab Med Sci & Lab Med, Zhenjiang 212013, Jiangsu, Peoples R China.

Abstract

Epidermal growth factor receptor (EGFR) signalling and the interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) are aberran......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer

科室

工具

服务